References
1. • ^ Charcot, J. Histologie de la sclerose en plaques. Gazette des hopitaux, Paris, 1868; 41: 554–555.
2. Braddom (MS Chapter) references 7-10 for Epidemiology
3. EPIDEMIOLOGY • ^ Marrie, RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004 Dec;3(12):709-18. Review. PMID 15556803
4. • ^ Sadovnick, AD, Ebers, GC, Dyment, DA, Risch, NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347:1728. PMID 8656905
5. Paty D. W., Arnold D. L. N Engl J Med 2002; 346:199-200, Jan 17, 2002. Editorials
6. Multiple Sclerosis Volume 343: 938-952 Sept 28, 2000 no.13
John H. Noseworthy, M.D.,
7. diagnostic criteria ( Annals of Neurology 2001; 50:121-127)
8. 2005 Revisions to the McDonald Diagnostic Criteria for MS, were published in 2005 (Annals of Neurology 2005; 58:840-846 ).
9. Management of Multiple Sclerosis. Richard A. Rudick, M.D., Jeffrey A. Cohen, M.D., NEJM. Volume 337:1604-1611 November 27, 1997 Number 22
10. Duquette P, Girard M, Knobler RL, et al. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology 1993; 43:655-661. Medline Similar articles
11. Hartung HP, Gonsette R, Konig N, et al. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet 2002; 360:2018-2025. Medline Similar articles Full article
12. Kos D, Kerckhofs E, Nagels G, D'hooghe MB, Ilsbroukx S.Neurorehabil Neural Repair. 2007 Apr 4 Origin of Fatigue in Multiple Sclerosis: Review of the Literature.
13. Roelecke,U., Kappos L., et al. 1997. Reduced glucose metabolism in the frontal cortex and basal ganglion of multiple sclerosis patients with fatigue: and 18 F. fluorodeoxyglucose position emission tomography study. Neurology 48:1566-71.
14. Sheean GL et al. 1997. An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120: 299-315.
15. Rice, C. L., et al.1992. Neuromuscular responses of patients with multiple sclerosis. Nerve and muscle 15:1123-32.
16. Oligiati,R.,et al. 1988. The increased energy costs of walking in multiple sclerosis: effect of spasticity, a taxi a comma and weakness. Archives of Physical Medicine and Rehabilitation 69: 846-49.
17. Giannantoni, A, et al. 1998. Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients. Neurology and Urodynamics 17: 89-98.
18. Tumani H, Uttner I.2007 May;254 Suppl 2:II69-II72.
